Annual CFO
-$27.93 M
+$50.98 M+64.61%
31 December 2023
Summary:
Kala Pharmaceuticals annual cash flow from operations is currently -$27.93 million, with the most recent change of +$50.98 million (+64.61%) on 31 December 2023. During the last 3 years, it has risen by +$62.77 million (+69.21%). KALA annual CFO is now -85.08% below its all-time high of -$15.09 million, reached on 31 December 2015.KALA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.72 M
+$4.49 M+48.72%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly cash flow from operations is currently -$4.72 million, with the most recent change of +$4.49 million (+48.72%) on 30 September 2024. Over the past year, it has dropped by -$1.77 million (-60.06%). KALA quarterly CFO is now -60.06% below its all-time high of -$2.95 million, reached on 30 September 2023.KALA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$32.48 M
-$1.77 M-5.77%
30 September 2024
Summary:
Kala Pharmaceuticals TTM cash flow from operations is currently -$32.48 million, with the most recent change of -$1.77 million (-5.77%) on 30 September 2024. Over the past year, it has increased by +$1.49 million (+4.37%). KALA TTM CFO is now -615.42% below its all-time high of -$4.54 million, reached on 31 March 2016.KALA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.6% | -60.1% | +4.4% |
| 3 y3 years | +69.2% | +81.9% | +69.4% |
| 5 y5 years | +48.4% | +79.4% | +64.1% |
KALA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.2% | -60.1% | +83.1% | -16.3% | +70.0% |
| 5 y | 5 years | at high | +74.2% | -60.1% | +85.5% | -16.3% | +70.0% |
| alltime | all time | -85.1% | +74.2% | -60.1% | +85.5% | -615.4% | +70.0% |
Kala Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.72 M(-48.7%) | -$32.48 M(+5.8%) |
| June 2024 | - | -$9.21 M(-15.0%) | -$30.71 M(+5.6%) |
| Mar 2024 | - | -$10.84 M(+40.9%) | -$29.09 M(+4.2%) |
| Dec 2023 | -$27.93 M(-64.6%) | -$7.70 M(+160.7%) | -$27.93 M(-17.8%) |
| Sept 2023 | - | -$2.95 M(-61.1%) | -$33.97 M(-27.2%) |
| June 2023 | - | -$7.59 M(-21.6%) | -$46.68 M(-27.6%) |
| Mar 2023 | - | -$9.68 M(-29.5%) | -$64.50 M(-18.3%) |
| Dec 2022 | -$78.91 M(-27.1%) | -$13.73 M(-12.3%) | -$78.91 M(-15.2%) |
| Sept 2022 | - | -$15.66 M(-38.4%) | -$93.08 M(-10.1%) |
| June 2022 | - | -$25.42 M(+5.5%) | -$103.50 M(+3.8%) |
| Mar 2022 | - | -$24.09 M(-13.7%) | -$99.68 M(-7.9%) |
| Dec 2021 | -$108.23 M(+19.3%) | -$27.90 M(+7.0%) | -$108.23 M(+1.9%) |
| Sept 2021 | - | -$26.08 M(+20.7%) | -$106.25 M(+0.4%) |
| June 2021 | - | -$21.61 M(-33.8%) | -$105.81 M(+2.3%) |
| Mar 2021 | - | -$32.64 M(+25.9%) | -$103.45 M(+14.1%) |
| Dec 2020 | -$90.69 M | -$25.92 M(+1.1%) | -$90.69 M(+9.3%) |
| Sept 2020 | - | -$25.64 M(+33.2%) | -$82.99 M(+3.4%) |
| June 2020 | - | -$19.25 M(-3.1%) | -$80.26 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$19.88 M(+9.2%) | -$81.43 M(-12.2%) |
| Dec 2019 | -$92.72 M(+71.3%) | -$18.21 M(-20.5%) | -$92.72 M(+2.5%) |
| Sept 2019 | - | -$22.91 M(+12.2%) | -$90.50 M(+8.0%) |
| June 2019 | - | -$20.43 M(-34.5%) | -$83.80 M(+15.5%) |
| Mar 2019 | - | -$31.17 M(+94.9%) | -$72.58 M(+34.1%) |
| Dec 2018 | -$54.12 M(+58.7%) | -$15.99 M(-1.4%) | -$54.12 M(+21.1%) |
| Sept 2018 | - | -$16.21 M(+76.1%) | -$44.70 M(+18.2%) |
| June 2018 | - | -$9.21 M(-27.6%) | -$37.81 M(+1.0%) |
| Mar 2018 | - | -$12.71 M(+93.7%) | -$37.45 M(+9.8%) |
| Dec 2017 | -$34.10 M(+24.7%) | -$6.56 M(-29.6%) | -$34.10 M(-2.2%) |
| Sept 2017 | - | -$9.33 M(+5.5%) | -$34.86 M(+3.5%) |
| June 2017 | - | -$8.85 M(-5.5%) | -$33.68 M(+4.7%) |
| Mar 2017 | - | -$9.36 M(+27.7%) | -$32.16 M(+17.6%) |
| Dec 2016 | -$27.35 M(+81.2%) | -$7.33 M(-10.0%) | -$27.35 M(+36.6%) |
| Sept 2016 | - | -$8.14 M(+11.0%) | -$20.02 M(+68.6%) |
| June 2016 | - | -$7.34 M(+61.6%) | -$11.88 M(+161.6%) |
| Mar 2016 | - | -$4.54 M | -$4.54 M |
| Dec 2015 | -$15.09 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual CFO year-on-year change?
- What is Kala Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly CFO year-on-year change?
- What is Kala Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM CFO year-on-year change?
What is Kala Pharmaceuticals annual cash flow from operations?
The current annual CFO of KALA is -$27.93 M
What is the all time high annual CFO for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual cash flow from operations is -$15.09 M
What is Kala Pharmaceuticals annual CFO year-on-year change?
Over the past year, KALA annual cash flow from operations has changed by +$50.98 M (+64.61%)
What is Kala Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of KALA is -$4.72 M
What is the all time high quarterly CFO for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly cash flow from operations is -$2.95 M
What is Kala Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, KALA quarterly cash flow from operations has changed by -$1.77 M (-60.06%)
What is Kala Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of KALA is -$32.48 M
What is the all time high TTM CFO for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM cash flow from operations is -$4.54 M
What is Kala Pharmaceuticals TTM CFO year-on-year change?
Over the past year, KALA TTM cash flow from operations has changed by +$1.49 M (+4.37%)